Position in BHC
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$894,992
-$306,286 QoQ
Shares Held
181,540
-18.4% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#68
of 220 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RITHOLTZ WEALTH MANAGEMENT holds $18,229,387 across 17 Drug Manufacturers - Specialty & Generic names. BHC ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
121,304 | $4,977,103 | |
| 2 | VTRS |
Viatris Inc
|
200,979 | $3,191,546 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
101,808 | $1,762,296 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
360,094 | $1,515,995 | |
| 5 | ALKS |
Alkermes plc.
|
25,487 | $1,335,518 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,905 | $1,032,186 | |
| 7 | BHC |
Bausch Health Companies Inc.
This page
|
181,540 | $894,992 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,490 | $694,201 |
All Filings in BHC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $894,992 | 181,540 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,201,278 | 222,459 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $554,582 | 79,796 | Shares | Sole | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||